0000947871-23-000750.txt : 20230713
0000947871-23-000750.hdr.sgml : 20230713
20230713200710
ACCESSION NUMBER: 0000947871-23-000750
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230713
DATE AS OF CHANGE: 20230713
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Galecto, Inc.
CENTRAL INDEX KEY: 0001800315
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371957007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39655
FILM NUMBER: 231087769
BUSINESS ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 45-70-70-52-10
MAIL ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 100
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: Galecto Inc.
DATE OF NAME CHANGE: 20200116
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORBIMED CAPITAL LLC
CENTRAL INDEX KEY: 0001157524
IRS NUMBER: 134133323
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
BUSINESS ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 739-6400
MAIL ADDRESS:
STREET 1: 601 LEXINGTON AVENUE
STREET 2: 54TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
144
1
primary_doc.xml
144
0001157524
XXXXXXXX
LIVE
0001800315
Galecto, Inc.
001-39655
75 State Street
Suite 100
Boston
MA
02109
45-70-70-52-10
The Biotech Growth Trust PLC
Shareholder
Common Stock
Bank of America
One Bryant Park
New York
NY
10036
14700
37485.00
25673474
07/13/2023
Nasdaq Stock Market
Common Stock
09/25/2020
Private placement
Issuer
N
14700
09/25/2020
Cash
N
The Biotech Growth Trust PLC
601 Lexington Ave.
54th Floor
New York
NY
10022
Common Stock
04/14/2023
3133
5827.38
OrbiMed Capital LLC is the portfolio manager of The Biotech Growth Trust PLC. The Biotech Growth Trust Plc sold 990 shares of Common Stock on April 17, 2023 at a per share price of $1.97 for gross proceeds of $1,950.30.
07/13/2023
/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Capital LLC, portfolio manager for The Biotech Growth Trust PLC